Edition:
India

China Resources Pharmaceutical Group Ltd (3320.HK)

3320.HK on Hong Kong Stock

8.83HKD
15 Jul 2019
Change (% chg)

-- (--)
Prev Close
HK$8.83
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
2,478,962
52-wk High
HK$13.16
52-wk Low
HK$8.50

Latest Key Developments (Source: Significant Developments)

China Resources Pharmaceutical Group Says Li Guohui Resigns As CFO
Friday, 5 Jul 2019 

July 5 (Reuters) - China Resources Pharmaceutical Group Ltd <3320.HK>::LI GUOHUI HAS RESIGNED AS AN EXECUTIVE DIRECTOR, CHIEF FINANCIAL OFFICER, VICE PRESIDENT.WENG JINGWEN HAS BEEN APPOINTED AS AN EXECUTIVE DIRECTOR, CHIEF FINANCIAL OFFICER, VICE PRESIDENT.  Full Article

China Resources Pharmaceutical Group Posts FY Profit Attributable Of HK$4.04 Bln
Thursday, 21 Mar 2019 

March 21 (Reuters) - China Resources Pharmaceutical Group Ltd <3320.HK>::FY REVENUE HK$189,689.1 MILLION VERSUS HK$172,532.2 MILLION.BOARD PROPOSED A FINAL DIVIDEND OF HK$0.13 PER SHARE.PROFIT FOR YEAR ATTRIBUTABLE HK$4.04 BILLION VERSUS HK$3.48 BILLION.  Full Article

China Resources Pharmaceutical Says Unit Got Acceptance Of Registration For Proposed Issuance Of Debt Financing Instrument
Thursday, 28 Feb 2019 

Feb 28 (Reuters) - China Resources Pharmaceutical Group Ltd <3320.HK>::UNIT GOT NOTICE OF ACCEPTANCE OF REGISTRATION FOR PROPOSED ISSUANCE OF DEBT FINANCING INSTRUMENT BY CR PHARMACEUTICAL.  Full Article

China Resources Pharmaceutical Group Updates On Public Issuance Of Corporate Bonds In PRC
Friday, 7 Dec 2018 

Dec 7 (Reuters) - China Resources Pharmaceutical Group Ltd <3320.HK>::UPDATES ON PROPOSED PUBLIC ISSUANCE OF CORPORATE BONDS IN PRC.AGGREGATE PRINCIPAL AMOUNT OF CORPORATE BONDS NOT MORE THAN RMB10 BILLION.UNIT GETS APPROVAL FOR THE PUBLIC ISSUANCE OF CORPORATE BONDS IN PRC.  Full Article

China Resources Pharmaceutical Group Posts FY ‍Profit Attributable HK$3,483 Mln​
Wednesday, 21 Mar 2018 

March 21 (Reuters) - China Resources Pharmaceutical Group Ltd <3320.HK>::FY ‍PROFIT ATTRIBUTABLE HK$3,483.0 MILLION, UP 23.4 PERCENT​.‍PROPOSED FINAL DIVIDEND PER SHARE HK$0.11​.‍FY REVENUE HK$172.53 BILLION VERSUS HK$156.71 BILLION​.  Full Article

China Resources Double-Crane Pharmaceutical announces 2017 dividend payment
Thursday, 15 Mar 2018 

March 15(Reuters) - China Resources Double-Crane Pharmaceutical Co Ltd <600062.SS>:Says it will pay a cash dividend of 0.97 yuan (pre-tax) per 10 shares to shareholders for 2017 and distribute two new shares for every 10 shares as stock dividends .  Full Article

China Resources Double-crane Pharmaceutical sets up industrial investment fund
Thursday, 8 Mar 2018 

March 8(Reuters) - China Resources Double-crane Pharmaceutical Co Ltd <600062.SS> ::Says it has successfully set up industrial investment fund with partners.  Full Article

China Resources Double-crane Pharmaceutical passes GMP recognition
Friday, 2 Feb 2018 

Feb 2(Reuters) - China Resources Double-crane Pharmaceutical Co Ltd <600062.SS>:Says it received goods manufacture practice (GMP) certificate from Beijing Food and Drug Administration .Certificate issued to large volume injection manufactured by the company and the valid period is until Jan. 8, 2023.  Full Article

China Resources Pharmaceutical Announces Proposed Capital Contribution To CR Leasing
Thursday, 28 Dec 2017 

Dec 28 (Reuters) - China Resources Pharmaceutical Group Ltd <3320.HK>::UNITS, ENTERS CAPITAL CONTRIBUTION AGREEMENT WITH CR LEASING (HONG KONG) & CR LEASING.DEAL FOR PROPOSED CAPITAL CONTRIBUTION OF RMB 889.4 MILLION​.  Full Article

China Resources Pharmaceutical Group Declares Special Dividend
Tuesday, 12 Dec 2017 

Dec 12 (Reuters) - China Resources Pharmaceutical Group Ltd <3320.HK>::RESOLVED TO DECLARE SPECIAL DIVIDEND IN AMOUNT OF HK$668.3 MILLION.  Full Article